Advantages of total parathyroidectomy in patients with secondary hyperparathyroidism induced by end stage renal disease

被引:3
|
作者
Iorga, Cristian [1 ,2 ]
Iorga, Cristina Raluca [1 ,2 ]
Andreiana, Iuliana [1 ,3 ]
Bengulescu, Iustinian [1 ,2 ]
Constantin, Traian [1 ,4 ]
Strambu, Victor [1 ,2 ]
机构
[1] Carol Davila Univ Med & Pharm, Fac Med, Bucharest, Romania
[2] Dr Carol Davila Clin Nephrol Hosp, Surg Clin, Bucharest, Romania
[3] Dr Carol Davila Clin Nephrol Hosp, Nephrol Clin, Bucharest, Romania
[4] Prof Dr Th Burghele Hosp, Dept Urol, Bucharest, Romania
来源
关键词
secondary hyperparathyroidism; total parathyroidectomy; parathormone; chronic kidney disease; hyperparathyroidism recurrence; MANAGEMENT; AUTOTRANSPLANTATION; MORTALITY; HORMONE; CKD;
D O I
10.3389/fendo.2023.1191914
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionSecondary hyperparathyroidism, as a result of chronic kidney disease could be treated medically or surgically. When pharmacotherapy fails, patients undergo surgery - parathyroidectomy, the curative treatment of secondary hyperparathyroidism (SHPT). There are currently 3 accepted surgical techniques, each with supporters or opponents - total parathyroidectomy, subtotal parathyroidectomy and parathyroidectomy with immediate autotransplantation.MethodsIn this paper we described our experience on a series of 160 consecutive patients diagnosed with secondary hyperparathyroidism who underwent surgery, in 27 cases it was totalization of the intervention (patients with previously performed subtotal parathyroidectomy or with supernumerary glands and SHPT recurrence). We routinely perform total parathyroidectomy, the method that we believe offers the best results.ResultsThe group of patients was studied according to demographic criteria, paraclinical balance, clinical symptomatology, pre- and postoperative iPTH (intact parathormone) values, SHPT recurrence, number of reinterventions. In 31 cases we found gland ectopy and in 15 cases we discovered supernumerary parathyroids. A percentage of 96.24% of patients with total parathyroidectomy did not show recurrence.DiscussionsAfter analyzing the obtained results, our conclusion was that total parathyroidectomy is the intervention of choice for patients suffering from secondary hyperparathyroidism when pharmacotherapy fails in order to prevent recurrence of the disease and to correct the metabolic parameters.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Effect of total parathyroidectomy in patients with secondary hyperparathyroidism: a retrospective study
    Gong, Xixiang
    Wang, Yi An
    Li, Chunqi
    Liao, Xue
    Li, Shihua
    Yang, Liping
    Jiang, Xuelian
    Sun, Yang
    Xu, Jianqing
    Tong, Zongwu
    Lu, Yongxin
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (05) : 1239 - 1245
  • [32] Effect of total parathyroidectomy in patients with secondary hyperparathyroidism: a retrospective study
    Xixiang Gong
    Yi An Wang
    Chunqi Li
    Xue Liao
    Shihua Li
    Liping Yang
    Xuelian Jiang
    Yang Sun
    Jianqing Xu
    Zongwu Tong
    Yongxin Lu
    International Urology and Nephrology, 2023, 55 : 1239 - 1245
  • [33] The potential for day case total parathyroidectomy in patients with secondary hyperparathyroidism
    McDonald, Sophie
    Al-Saadi, Nina
    Chang, Jessica
    Neophytou, Christodolous
    Houghton, Andrew
    BRITISH JOURNAL OF SURGERY, 2022, 109
  • [34] Total parathyroidectomy improves survival of hemodialysis patients with secondary hyperparathyroidism
    Iwamoto, Noriyuki
    Sato, Nodoka
    Nishida, Masaya
    Hashimoto, Tetsuya
    Kobayashi, Hiroyuki
    Yamasaki, Satoru
    Ono, Toshihiko
    Nishimura, Masato
    Tokoro, Toshiko
    Sakoda, Chikako
    Murakawa, Mayuko
    Okino, Koji
    Okamoto, Yuu
    Imai, Ryo
    Adachi, Naoto
    Ninomiya, Kanji
    Mabuchi, Hisao
    Koyama, Masaki
    Nakanouchi, Tsuneyuki
    Iseki, Kunitoshi
    JOURNAL OF NEPHROLOGY, 2012, 25 (05) : 755 - 763
  • [35] TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH CHRONIC-RENAL-FAILURE BY TOTAL PARATHYROIDECTOMY AND PARATHYROID AUTOGRAFT
    DIETHELM, AG
    ADAMS, PL
    MURAD, TM
    DANIEL, WW
    WHELCHEL, JD
    RUTSKY, EA
    ROSTAND, SG
    ANNALS OF SURGERY, 1981, 193 (06) : 777 - 793
  • [36] Race is a major determinant of secondary hyperparathyroidism (SecHPT) in end stage renal disease
    Gupta, A
    Kallenbach, LR
    Zasuwa, G
    Divine, GW
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S686 - S686
  • [37] Outcome of parathyroidectomy for patients with renal disease and hyperparathyroidism: predictors for recurrent hyperparathyroidism
    Low, Tsu-Hui
    Clark, Jonathan
    Gao, Kan
    Eris, Josette
    Shannon, Kerwin
    O'Brien, Christopher
    ANZ JOURNAL OF SURGERY, 2009, 79 (05) : 378 - 382
  • [38] Relative contribution of secondary hyperparathyroidism to anemia in end-stage renal disease
    Ifudu, O
    DIALYSIS & TRANSPLANTATION, 2002, 31 (04) : 247 - 249
  • [39] Young age, male sex, and end-stage renal disease with secondary hyperparathyroidism as risk factors for intraoperative hyperkalemia during parathyroidectomy
    Yang, Ya-Ling
    Lu, Hsiao-Feng
    Chung, Kuan-Chi H.
    Jawan, Bruno
    Chou, Fong-Fu
    JOURNAL OF CLINICAL ANESTHESIA, 2015, 27 (03) : 195 - 200
  • [40] Secondary Hyperparathyroidism in End-Stage Renal Disease: No Longer a Matter for Surgeons?
    Cozzolino, Mario
    Elli, Francesca
    Carugo, Stefano
    Ciceri, Paola
    BLOOD PURIFICATION, 2016, 42 (01) : 44 - 48